EUVIMEDEUVIMED entdecken
Crossref

Multidrug resistance and recurrence in urinary bacteraemia among cancer patients

Ignacio Grafia, Alba Moll-Febrer, Solanche Jasmin Santillán, Clara Rodrigo, Eva Lillo, Néstor López, Berta Fidalgo, Verónica Rico-Caballero, Mateu Espasa-Soley, Daniel N Marco iD, Cristina Pitart, Javier Marco-Hernández und 11 weitere

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Ignacio Grafia und 22 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. Hauptthemen laut MEDLINE: Bacteremia, Drug Resistance, Multiple, Bacterial, Neoplasms, Anti-Bacterial Agents. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urinary tract infections (UTI) in oncological patients can lead to bacteraemia (bUTI), increasing morbidity and mortality. This study assessed the characteristics, outcomes and recurrence of bUTI in oncological patients.

Methods

A retrospective cohort study was conducted at Hospital Clinic, Barcelona, from 2008 to 2019. All episodes of bUTI in oncological patients were analysed. Multivariable regression models identified independent risk factors for multidrug-resistant (MDR) Gram-negative bacilli (GNB), recurrent bUTI and related mortality.

Results

A total of 561 bUTI episodes were identified in 478 oncological patients. Urinary tract involvement due to neoplasm was present in 62.2%, and 59.4% had urinary tract instrumentation. Prior UTI-related admission without bacteraemia was reported in 63.8%. Following bUTI, oncological treatment was delayed in 47% and stopped in 33.6% of cases. GNB caused 87.3% of episodes, with Escherichia coli and Klebsiella spp. being the most common pathogens. Enterococcus spp. and Pseudomonas aeruginosa were frequent, particularly in patients with urinary instrumentation. MDR-GNB caused 19.6% of episodes, and 23.4% of cases received inappropriate empirical antibiotic therapy (IEAT). Recurrent bUTI occurred in 14.0% of patients. A simple predictive score efficiently identified patients at high risk of recurrence. Thirty-day mortality was 15.3%, and bUTI-related mortality was 10.7%, with absence of fever, septic shock and carbapenemase-producing Enterobacterales linked to higher related mortality. Conclusion bUTI in oncological patients is predominantly caused by GNB, with high rates of MDR isolates and high mortality. IEAT is common, and recurrence is significant, highlighting the need for targeted preventive strategies and optimized empirical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaDrug Resistance, Multiple, BacterialNeoplasmsAnti-Bacterial AgentsUrinary Tract InfectionsHumansMaleRetrospective StudiesFemaleAgedMiddle AgedRisk FactorsRecurrenceAged, 80 and overGram-Negative BacteriaAdultSpainGram-Negative Bacterial Infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
  • Internal Medicine Department, Complex Hospitalari Universitari Moisés Broggi, Sant Joan Despí, Barcelona, Spain.
  • Department of Medicine, Universitat de Barcelona (UB), Barcelona, Spain.
  • Radiation Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
  • Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
  • Microbiology Department, Centre Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain.

ORCID-Profile: Daniel N Marco, Alex Soriano, Pedro Puerta-Alcalde

Förderung

  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Grafia, I., Moll-Febrer, A., Santillán, S. J., Rodrigo, C., Lillo, E., López, N., Fidalgo, B., Rico-Caballero, V., Espasa-Soley, M., Marco, D. N., Pitart, C., Marco-Hernández, J., Fernández, S., Zamora, C., Padrosa, J., Garcia de Herreros, M., Herrera, S., Viladot, M., Mensa, J., …, & Puerta-Alcalde, P. (2025). Multidrug resistance and recurrence in urinary bacteraemia among cancer patients. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf335

Vancouver

Grafia I, Moll-Febrer A, Santillán SJ, Rodrigo C, Lillo E, López N, et al. Multidrug resistance and recurrence in urinary bacteraemia among cancer patients. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf335

BibTeX
@article{Grafia2025,
  author = {Grafia, Ignacio and Moll-Febrer, Alba and Santillán, Solanche Jasmin and Rodrigo, Clara and Lillo, Eva and López, Néstor and Fidalgo, Berta and Rico-Caballero, Verónica and Espasa-Soley, Mateu and Marco, Daniel N and Pitart, Cristina and Marco-Hernández, Javier and Fernández, Sara and Zamora, Carles and Padrosa, Joan and Garcia de Herreros, Marta and Herrera, Sabina and Viladot, Margarita and Mensa, Josep and Llavata, Lucía and Tuca, Albert and Soriano, Alex and Puerta-Alcalde, Pedro},
  title = {Multidrug resistance and recurrence in urinary bacteraemia among cancer patients},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf335}
}
Kostenlos starten →